{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:40Z","timestamp":1790838580015,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health \/ National Institute of Arthritis and Musculoskeletal and Skin Diseases","award":["K08-AR074562"],"award-info":[{"award-number":["K08-AR074562"]}]},{"name":"Charles H. Hood Foundation Child Health Research Award"},{"name":"Arthritis National Research Foundation All Arthritis Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10875-022-01346-x","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:02:45Z","timestamp":1660694565000},"page":"1766-1777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8919-5243","authenticated-orcid":false,"given":"Thomas F.","family":"Michniacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Walkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"DeMeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hannibal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Basiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailey","family":"Brodeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Simoneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"issue":"5","key":"1346_CR1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee PY, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020;146(5):1194-1200.e1. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.033.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1346_CR2","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","volume":"11","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun. 2020;11(1):5341. https:\/\/doi.org\/10.1038\/s41467-020-18925-4.","journal-title":"Nat Commun"},{"key":"1346_CR3","doi-asserted-by":"publisher","unstructured":"N. P. D. Liau et al, (2018) \u201cThe molecular basis of JAK\/STAT inhibition by SOCS1,\u201d Nat Commun, vol. 9, no. 1, Art. no. 1, https:\/\/doi.org\/10.1038\/s41467-018-04013-1","DOI":"10.1038\/s41467-018-04013-1"},{"key":"1346_CR4","doi-asserted-by":"publisher","unstructured":"J K\u00f6rholz et al 2021 One gene, many facets: multiple immune pathway dysregulation in SOCS1 haploinsufficiency Front Immunol 12 680334 https:\/\/doi.org\/10.3389\/fimmu.2021.680334","DOI":"10.3389\/fimmu.2021.680334"},{"issue":"7814","key":"1346_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","volume":"583","author":"JED Thaventhiran","year":"2020","unstructured":"Thaventhiran JED, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. 2020;583(7814):90\u20135. https:\/\/doi.org\/10.1038\/s41586-020-2265-1.","journal-title":"Nature"},{"key":"1346_CR6","unstructured":"\u201cPathology handbook,\u201d Cytogenetics, cancer cytogenomic array, blood or bone marrow. https:\/\/www.pathology.med.umich.edu\/handbook\/#\/details\/888 (accessed Mar. 06, 2022)."},{"key":"1346_CR7","unstructured":"\u201cPathology handbook,\u201d Chromosomal microarray analysis, blood. https:\/\/www.pathology.med.umich.edu\/handbook\/#\/details\/4760 (accessed Mar. 06, 2022)."},{"key":"1346_CR8","unstructured":"\u201cGenetic testing for inborn error of immunity,\u201d Blueprint Genetics. https:\/\/blueprintgenetics.com\/tests\/panels\/hematology\/comprehensive-immune-and-cytopenia-panel\/ (accessed Feb. 20, 2022)."},{"key":"1346_CR9","unstructured":"\u201cFlow FISH telomere testing technology | RepeatDx,\u201d Oct. 26, 2015. https:\/\/repeatdx.com\/flow-fish\/ (accessed Mar. 06, 2022)."},{"key":"1346_CR10","unstructured":"\u201cDiagnostic Immunology Lab | Cancer and blood diseases.\u201d https:\/\/www.cincinnatichildrens.org\/service\/c\/cancer-blood\/hcp\/clinical-laboratories\/diagnostic-lab (accessed Mar. 06, 2022)."},{"issue":"4","key":"1346_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/jir.2017.0127","volume":"38","author":"H Kim","year":"2018","unstructured":"Kim H, et al. Development of a validated interferon score using NanoString technology. J Interferon Cytokine Res. 2018;38(4):171\u201385. https:\/\/doi.org\/10.1089\/jir.2017.0127.","journal-title":"J Interferon Cytokine Res"},{"key":"1346_CR12","unstructured":"\u201cOMIM - Online Mendelian Inheritance in Man.\u201d https:\/\/www.omim.org\/. Accessed 27 Apr 2022."},{"key":"1346_CR13","unstructured":"S. A. Savage and E. Cook, Dyskeratosis congenita and telomere biology disorders: diagnosis and management guidelines, 1st ed. 2015."},{"issue":"6","key":"1346_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1084\/jem.20030789","volume":"198","author":"L Gorelik","year":"2003","unstructured":"Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med. 2003;198(6):937\u201345. https:\/\/doi.org\/10.1084\/jem.20030789.","journal-title":"J Exp Med"},{"key":"1346_CR15","doi-asserted-by":"publisher","unstructured":"A.-C. Lundell et al. (2017) \u201cIFN type I and II induce BAFF secretion from human decidual stromal cells,\u201d Sci Rep, vol. 7, no. 1, Art. no. 1, https:\/\/doi.org\/10.1038\/srep39904.","DOI":"10.1038\/srep39904"},{"issue":"2","key":"1346_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3960\/jslrt.18018","volume":"58","author":"H Iwafuchi","year":"2018","unstructured":"Iwafuchi H. The histopathology of bone marrow failure in children. J Clin Exp Hematop. 2018;58(2):68\u201386. https:\/\/doi.org\/10.3960\/jslrt.18018.","journal-title":"J Clin Exp Hematop"},{"key":"1346_CR17","doi-asserted-by":"publisher","unstructured":"D. Metcalf et al. (1999) \u201cAberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1,\u201d Leukemia vol 13 no 6 Art no 6. https:\/\/doi.org\/10.1038\/sj.leu.2401440","DOI":"10.1038\/sj.leu.2401440"},{"key":"1346_CR18","doi-asserted-by":"publisher","unstructured":"J. N. P. Smith, V. S. Kanwar, and K. C. MacNamara, \u201cHematopoietic stem cell regulation by type I and II interferons in the pathogenesis of acquired aplastic anemia,\u201d Frontiers in Immunology, vol. 7, 2016, Accessed: May 04, 2022. [Online]. Available: https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fimmu.2016.00330","DOI":"10.3389\/fimmu.2016.00330"},{"issue":"1","key":"1346_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.gene.6364352","volume":"8","author":"H Dickensheets","year":"2007","unstructured":"Dickensheets H, et al. Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun. 2007;8(1):21\u20137. https:\/\/doi.org\/10.1038\/sj.gene.6364352.","journal-title":"Genes Immun"},{"issue":"1","key":"1346_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood.v97.1.221","volume":"97","author":"B Sporri","year":"2001","unstructured":"Sporri B, Kovanen PE, Sasaki A, Yoshimura A, Leonard WJ. JAB\/SOCS1\/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood. 2001;97(1):221\u20136. https:\/\/doi.org\/10.1182\/blood.v97.1.221.","journal-title":"Blood"},{"issue":"4","key":"1346_CR21","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10753-018-0802-y","volume":"41","author":"L Zhang","year":"2018","unstructured":"Zhang L, Xu C, Chen X, Shi Q, Su W, Zhao H. SOCS-1 suppresses inflammation through inhibition of NALP3 inflammasome formation in smoke inhalation-induced acute lung injury. Inflammation. 2018;41(4):1557\u201367. https:\/\/doi.org\/10.1007\/s10753-018-0802-y.","journal-title":"Inflammation"},{"issue":"3","key":"1346_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1096\/fj.10-170597","volume":"25","author":"J Strebovsky","year":"2011","unstructured":"Strebovsky J, Walker P, Lang R, Dalpke AH. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus. FASEB J. 2011;25(3):863\u201374. https:\/\/doi.org\/10.1096\/fj.10-170597.","journal-title":"FASEB J"},{"issue":"1","key":"1346_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nrd.2017.267","volume":"17","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O\u2019Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;17(1):78. https:\/\/doi.org\/10.1038\/nrd.2017.267.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"1346_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545\u201358. https:\/\/doi.org\/10.1038\/s41577-018-0029-z.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1346_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","volume":"14","author":"AM Shawky","year":"2022","unstructured":"Shawky AM, Almalki FA, Abdalla AN, Abdelazeem AH, Gouda AM. A comprehensive overview of globally approved JAK inhibitors. Pharmaceutics. 2022;14(5):1001. https:\/\/doi.org\/10.3390\/pharmaceutics14051001.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1346_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13075-019-1964-1","volume":"21","author":"IB McInnes","year":"2019","unstructured":"McInnes IB, et al. Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations. Arthritis Res Ther. 2019;21(1):183. https:\/\/doi.org\/10.1186\/s13075-019-1964-1.","journal-title":"Arthritis Res Ther"},{"key":"1346_CR27","unstructured":"C. for D. E. and Research, \u201cFDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions,\u201d FDA, Jan. 2022, Accessed: Mar. 06, 2022. [Online]. Available: https:\/\/www.fda.gov\/drugs\/fda-drug-safety-podcasts\/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death"},{"issue":"4","key":"1346_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MBC.0000000000000249","volume":"26","author":"S-H Hung","year":"2015","unstructured":"Hung S-H, Lin H-C, Chung S-D. Association between venous thromboembolism and iron-deficiency anemia: a population-based study. Blood Coagul Fibrinolysis. 2015;26(4):368\u201372. https:\/\/doi.org\/10.1097\/MBC.0000000000000249.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1346_CR29","doi-asserted-by":"publisher","unstructured":"A. Schifferli et al., \u201cUnderstanding immune thrombocytopenia: looking out of the box,\u201d Frontiers in Medicine, vol. 8, 2021, Accessed: Feb. 26, 2022. [Online]. Available: https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fmed.2021.613192","DOI":"10.3389\/fmed.2021.613192"},{"key":"1346_CR30","doi-asserted-by":"crossref","unstructured":"\u201cThe ITP syndrome: pathogenic and clinical diversity | Blood | American Society of Hematology.\u201d https:\/\/ashpublications.org\/blood\/article\/113\/26\/6511\/26188\/The-ITP-syndrome-pathogenic-and-clinical-diversity (accessed Mar. 06, 2022).","DOI":"10.1182\/blood-2009-01-129155"},{"issue":"1","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","volume":"134","author":"J Hadjadj","year":"2019","unstructured":"Hadjadj J, et al. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134(1):9\u201321. https:\/\/doi.org\/10.1182\/blood-2018-11-887141.","journal-title":"Blood"},{"issue":"5","key":"1346_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1542\/pir.2017-0308","volume":"40","author":"IK Chinn","year":"2019","unstructured":"Chinn IK, Orange JS. Immunodeficiency disorders. Pediatr Rev. 2019;40(5):229\u201342. https:\/\/doi.org\/10.1542\/pir.2017-0308.","journal-title":"Pediatr Rev"},{"key":"1346_CR33","doi-asserted-by":"publisher","unstructured":"FA. Bonilla et al. (2015) \u201cPractice parameter for the diagnosis and management of primary immunodeficiency,\u201d J. Allergy Clin. Immunol., vol. 136, no. 5, pp. 1186-1205.e1\u201378, https:\/\/doi.org\/10.1016\/j.jaci.2015.04.049","DOI":"10.1016\/j.jaci.2015.04.049"},{"issue":"6","key":"1346_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10875-019-00656-x","volume":"39","author":"HAF Yska","year":"2019","unstructured":"Yska HAF, Elsink K, Kuijpers TW, Frederix GWJ, van Gijn ME, van Montfrans JM. Diagnostic yield of next generation sequencing in genetically undiagnosed patients with primary immunodeficiencies: a systematic review. J Clin Immunol. 2019;39(6):577\u201391. https:\/\/doi.org\/10.1007\/s10875-019-00656-x.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1346_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s10875-018-0489-8","volume":"38","author":"JR Heimall","year":"2018","unstructured":"Heimall JR, et al. Use of genetic testing for primary immunodeficiency patients. J Clin Immunol. 2018;38(3):320\u20139. https:\/\/doi.org\/10.1007\/s10875-018-0489-8.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01346-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:59:06Z","timestamp":1744142346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01346-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01346-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental studies were approved by the Institutional Review Board at Boston Children\u2019s Hospital. This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was provided by participants or legal guardians. The patient\u2019s family additionally provided authorization to report and publish her case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate\/Consent for Publication"}},{"value":"No authors have competing interests. Michniacki, Saad, Hannibal, DeMeyer, Brown, Mohan, Lee, Ngo, Simoneau, Chen, Brodeur, Du, Basiaga, Horst: No disclosures. Frame: Research Funding from Jazz Pharmaceuticals. Walkovich:\u2008Horizon Pharmaceuticals: Honoraria, Membership on an entity\u2019s Board of Directors or advisory committees; Pharming: Honoraria, Membership on an entity\u2019s Board of Directors or advisory committees; Swedish Orphan Biovitrum AB (Sobi): Consultancy, Honoraria; X4 Pharmaceuticals: Other: Local PI for clinical trial involving mavorixafor and patients with neutropenia.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}